Amferia

Molndal, Sweden · Founded 2018 · Privately Held (backing)

Developer of medical devices designed for the global antibiotic resistance crisis. Amferia is based in Molndal, Sweden and was founded in 2018. Its last reported valuation was $8.9 million in Sep 2024. It has raised $7.9 million.

Last reported valuation
$8.9M
Oct 2026
Priced at
—
Total raised
$7.9M
Last round
—

Who backs Amferia?

10 investors
InvestorType
European UnionOther
Almi InvestVenture capital
Chalmers VenturesVenture capital
Alexander HarsAngel
British Corinthian Properties—
Swedbank—
Sätila Impact Investment—
VentureCup—
Vinnova—
Västra Götalandsregion—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Amferia investors

10 investors are on record for Amferia, including European Union, Almi Invest, Chalmers Ventures and Alexander Hars.

Free account
More of Amferia with a free account
  • ·Watch Amferia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Amferia. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View